GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (GREY:BNZPF) » Definitions » Total Long-Term Liabilities

Biosenic (Biosenic) Total Long-Term Liabilities : $17.08 Mil (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biosenic Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Biosenic's Total Long-Term Liabilities for the quarter that ended in Jun. 2023 was $17.08 Mil.


Biosenic Total Long-Term Liabilities Historical Data

The historical data trend for Biosenic's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenic Total Long-Term Liabilities Chart

Biosenic Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.57 12.23 14.26 2.64 16.79

Biosenic Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.11 2.64 15.87 16.79 17.08

Biosenic Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


Biosenic Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biosenic's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosenic (Biosenic) Business Description

Industry
Traded in Other Exchanges
Address
Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, Gosselies, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Biosenic (Biosenic) Headlines

From GuruFocus

Q2 2021 Bone Therapeutics SA Earnings Call Transcript

By GuruFocus Research 03-03-2024